Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating activities      
Net income/(loss) $ 355 $ 244 $ (132)
Adjustments to reconcile net income/(loss) to net cash provided by/(used in) operating activities:      
Depreciation and amortization 77 95 98
(Recovery of)/provision for doubtful accounts (2) 21 37
Impairments, net 0 6 209
Deferred income taxes (39) (1) (23)
Stock-based compensation 33 28 21
Gain on asset sale, net (35) 0 0
Early extinguishment of debt 2 18 0
Net change in assets and liabilities:      
Trade receivables 16 25 (38)
Prepaid expenses (6) (9) 3
Other current assets (3) (45) 1
Accounts payable, accrued expenses and other current liabilities 14 39 (46)
Deferred revenues 22 16 (54)
Payments of development advance notes (52) (32) (17)
Proceeds from development advance notes 4 2 1
Other, net 13 19 7
Net cash provided by operating activities 399 426 67
Investing activities      
Property and equipment additions (39) (37) (33)
Acquisition of hotel brand (44) 0 0
Loan advances 0 0 (1)
Loan repayments 0 3 3
Proceeds from asset sales, net 263 0 0
Other, net (1) 0 0
Net cash provided by/(used in) investing activities 179 (34) (31)
Financing activities      
Proceeds from borrowings 400 45 1,244
Principal payments on long-term debt (404) (574) (760)
Finance lease, principal payments (5) (5) (5)
Debt issuance costs (4) 0 (10)
Dividends to stockholders (116) (82) (53)
Repurchases of common stock (448) (107) (50)
Exercise of stock options 4 17 0
Net share settlement of incentive equity awards (11) (7) (4)
Other, net 0 0 1
Net cash (used in)/provided by financing activities (584) (713) 363
Effect of changes in exchange rates on cash, cash equivalents and restricted cash (4) (1) 0
Net (decrease)/increase in cash, cash equivalents and restricted cash (10) (322) 399
Cash, cash equivalents and restricted cash, beginning of period 171 493 94
Cash, cash equivalents and restricted cash, end of period $ 161 $ 171 $ 493